CellaVision AB (publ) Interim report: January 1 - March 31 2011
Strong start to the year
January 1 - March 31, 2011
- Net sales rose by 45 % to SEK 30.6 million (21.1).
- Operating profit was SEK 2.5 million (-4.4).
- Profit after tax was SEK 0.1 million (-4.7).
- Earnings per share were SEK 0.00 (-0.20).
- Cash and cash equivalents at the end of the quarter were SEK 40.2 million (18.0).
CellaVision in brief
| (SEK million) | Jan-March 2011 | Jan-March 2010 | Full year 2010 | |
| Net sales | 30.6 | 21.1 | 131.6 | |
| Gross profit | 20.8 | 14.0 | 87.6 | |
| Operating profit | 2.5 | -4.4 | 13.9 | |
| Profit before tax | 0.3 | -4.7 | 10.7 | |
| Cash flow | 4.4 | -4.0 | 13.8 | |
CEO comments on the continuing positive trend
"Sales continued to grow at a fast rate in the first quarter this year. In Europe and North America our partners are working at the same high intensity as before, and we are seeing the results. During the period we have also actively trained and supported our partners in South-East Asia where demand for our products is beginning to take off.
We continue to see a strong underlying demand for our products. Consequently our great challenge is to adapt both production and organization to this demand. In the coming quarters we will increase investment in our own organization by adding employees in support functions for distributors and end customers, while also taking measures to strengthen product supply.
As we report on our global sales our thoughts naturally also turn to Japan and the Japanese people who were severely hit by the earthquake earlier this year. As far as we can judge neither our partner Sysmex nor our own operations in Japan were affected. It is at present difficult to assess how CellaVision's business will be affected in the coming quarters, but in the short term we believe the effect will have limited consequences for our sales and the supply of Japanese components.
CellaVision continues to work with strong determination on our plan for further international market expansion and continued product development in 2011."
Yvonne Mårtensson, CEO, CellaVision AB
For further information, please contact:
Yvonne Mårtensson, CEO, Cell: +46 708 33 77 82, email: yvonne.martensson@cellavision.se
Johan Wennerholm, CFO, Cell: +46 708 33 81 68, email: johan.wennerholm@cellavision.se